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Preparation of the phosphate-buffer minimal salts medium 
Growth media composed of K2HPO4 (4.4 g/L), KH2PO4 (1.7 g/L) and yeast extract (50 mg/L) 
was sterilized by autoclaving (121oC, 20 min.) after which it was supplemented with 10% salts 
medium. Filter sterilized (0.20 μm) 100x salts stock contained MgSO4x7H2O (19.5 g/L), 
MnSO4x4H20 (6.6 g/L), FeSO4x7H20 (1 g/L), CaCl2x6H20 (0.447 g/L) and several drops of 
concentrated H2SO4 to prevent precipitation of basic salts. Depending of the experiment organic 
carbon source in the form of glucose and nitrogen source, in the form of NH4Cl, were filter 
sterilized and added to the growth medium. 
DNA extraction procedure, PCR amplifications and analysis details 
Cultures were centrifuged (10 000 g, 10 min) and pellets were resuspended in the elution buffer. 
DNA was extracted from the harvested cells by combining chemical (addition of Lysis buffer and 
Proteinase K) and mechanical lysis steps (agitation for 12 min at max. speed, Vortex-Genie 
(MoBio). After centrifugation (11 000 g, 30 s) supernatant containing DNA was collected and 
transferred onto the Nucleospin Microbial DNA Column. DNA was purified by washing silica 
membrane with 2 different buffers following centrifugation steps (11 000 g, 30 s). DNA was 
eluted from the column after the addition of the elution buffer, incubation at room temperature (1 
min) and subsequent centrifugation step (11 000 g, 30 s). Quality and quantity of the extracted 
DNA was assessed by NanoDrop spectrophotometer (BioSpec-nano, Shimadzu). PCR program 
used for amplification of the V4 16S rRNA region with primers 515/806 included: 94°C (for 3 
min), 30 cycles (5 cycle used on PCR products) of 94°C (for 30 s), 53°C (for 40 s) and 72°C (for 




PCR products are checked on 2% agarose gel of bands. After MiSeq platform analysis sequences 
were depleted of barcodes and primers, then sequences < 150 bp removed, sequences with 
ambiguous base calls and with homopolymer runs exceeding 6 bp were also removed. Sequences 
were denoised, OTUs generated and chimeras removed. 



















Tramadol as C 
and N source 
50 20 - - - - NA 
2 
Glucose as C 
source, Tramadol 
as N source 
50 20 1000 - - - NA 
3 
NH4Cl as N 
source, Tramadol 
as C source 
50 20 - - 170 - NA 
4 
Glucose as C 
source; NH4Cl as 
N source 
50 20 1150 - 1000 - 2:1 
5 
Glucose as C 
source; NH4Cl as 
N source 
50 20 500 - 200 - 4:1 
6 
Glucose as C 
source; NH4Cl as 
N source 
50 20 1000 - 100 - 18:1 
7 
Glucose as C 
source; NH4Cl as 
N source 
50 20 1000 - 170 - 10:1 
8 
Glycerol as C 
source; NH4Cl as 
N source 
50 20 - 600 100 - 10:1 
9 
Glucose as C 
source; NH4NO3 
as N source 
50 20 1000 - - 130 10:1 
*the initial C:N ratio established by supplementation of a minimal salt medium (MSM) with the selected 




Table S2. Data on tramadol (TRAM) removal and presence of transformation products (TPs) during the enrichment performed in the 
minimal mineral mediu (MSM) containing TRAM and different combinations of selected carbon (C) and nitrogen (N) sources.  





2 months 4 months 7 months 8 months 12 months 2 months 4 months 7 months 8 months 12 months 
TRAM + NH4Cl <1 N/A N/A N/A N/A ND N/A N/A N/A N/A 
TRAM + C (glu) <1 N/A N/A N/A N/A ND N/A N/A N/A N/A 
TRAM + [C (glu) + N 
(NH4Cl)]; C: N = 2:1 
<1 N/A N/A N/A N/A ND N/A N/A N/A N/A 
TRAM + [C (glu) + N 
(NH4Cl)]; C: N = 4:1 
<1 <1 N/A N/A N/A ND ND N/A N/A N/A 
TRAM + [C (glu) + N 
(NH4Cl)]; C: N = 10:1 
<1 <1 33 60 83 ND Trace* D** D** D** 
TRAM + [C (glu) + N 
(NH4Cl)]; C: N = 18:1 
<1 <1 N/A N/A N/A ND ND N/A N/A N/A 
TRAM + [C (gly) + N 
(NH4Cl)]; C: N = 10:1 
<1 <1 N/A N/A N/A ND ND N/A N/A N/A 
TRAM + [C (glu) + N 
(NH4NO3)]; C: N = 10:1 
<1 N/A N/A N/A N/A ND N/A N/A N/A N/A 
Glu – glucose; gly – glycerol, N/A – not applicable; ND – non-detectable; D - detectable; *- trace amount of N-desmethyl tramadol; ** detectable 




Validation of the analytical protocol 
 
The validation of the applied analytical protocol comprised determination of linearity range, 
method quantitation limit (MQL), instrumental precision, method precision, quality check (QC) 
variability and measurement accuracy. 
Linearity of the response was determined from 8-point external standard calibration curves, 
constructed by injecting standard solutions containing analytes in the concentration range from 
0.02 ng/µl to 2.5 ng/µl.  
MQL was defined as the lowest point of the calibration curve. 
Instrumental precision was assessed as a relative standard deviation of 4 replicate analyses of a 
standard solution. 
Method precision was assessed as a relative standard deviation of 4 replicates prepared by 
aplying all steps included in the analytical protocol, including a sample centrifugation and 
dilution before the analysis. 
QC variability was assessed as a relative standard deviation of QC sample (2 ng/µL) which was 
analysed after every 10-12 sample analyses.  
Matrix effect (signal suppression or enhacement) was determined by comparing the average 
response (n = 4) of deuterated TRAM and N-DM-TRAM  spiked (0.2 ng/mL) into the diluted 
sample (ASAMPLE) collected at the beginning (t0) and at the end (tend) of the biodegradation 
experiment with their average response (ASTD; n = 4) in a matrix-free standard solution (0.2 
ng/mL), as follows.  
ME (%) = (1 – ASAMPLE/ASTD) * 100 
The measurement accuracy was determined by comparing the average concentration determined 




The determined validation parameters are presented in the Table S3. 
   





Linearity (r2) 0.9961 0.9991 
MQL (mg L-1 ) 0.2 0.2 
Instrumental precision (%) 1.3 1.7 
Method precision (%) 0.9 1.8 
QC variability (%) 1.5 1.9 
Matrix effect t0 3.3 ND 
Matrix effect tend 9.9 ND 
Determination accuracy (%)  96.7 100.7 
















































































Fig. S1. Total ion chromatograms of the samples collected at the end of the preliminary 
biodegradation experiment (2 weeks) performed with the original sludge culture at four selected 






















































Fig. S2. Total ion chromatograms (TIC) of the samples collected at the beginning (bottom) and at 
the end (top) of the biodegradation experiment performed with an enriched sludge culture, 







































Fig. S3. Total ion chromatograms (TIC) of the samples collected at the beginning (bottom) and at 
the end (top) of the biodegradation experiment performed with an enriched sludge culture, 





























































Fig. S4. Extracted ion chromatograms (XIC) of TRAM and its biotransformation products (TPs) 
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Fig. S5. Accurate mass spectra of tramadol (TRAM) obtained by applying two different mass-
spectrometric conditions: A) Sample cone voltage = 60 V (in-source fragmentation); B) Sample 


































































Fig. S6. Accurate mass spectra of tramadol (TRAM) and N-desmethyltramadol (N-DM-TRAM) 
acquired by sample cone voltages of 60 V and 50 V (in-source fragmentation), respectively. 





















Δ = -0.8 mDa
C8H9O
Δ = -0.8 mDa
C14H20NO
Δ = -0.7 mDa
C14H22NO2




Fig. S7. Accurate mass spectra of N,N-didesmethyltramadol (N,N-di-DM-TRAM). Sample from 
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C11H11O
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C8H9O
Δ = +0.2 mDa
C14H17O
Δ = +0.5 mDa
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Fig. S8. Accurate mass spectra of tramadol transformation products 277a,b,c acquired by 
applying a collision energy, CE = 20 eV and sample cone voltage, CV = 30 eV. Sample from 



















































TP 249 = N-DM-TRAM
 
 
Fig. S9. Accurate mass spectra of N-desmethy tramadol (N-DM TRAM) and TRAM TPs 277a-c. 








































TRAM TP  277a
N-acetylation
 
Fig. S10. Tentative biotransformation pathway of tramadol (TRAM) observed under aerobic 
















Fig. S11. Ratios of summed-up molar concentration of TRAM and its TPs determined during the 
aerobic biodegradation experiment performed  with (w/) and without (w/o) glucose 








Fig. S12. Non-metric multi-dimensional scaling (nMDS) plot showing similarities in community 
structure (genus level) between original activated sludge culture collected at the WWTP (Zagreb) 
site (OAS) and the enriched activated sludge culture sampled at day 0. (EAS 0d) and 4th Day 
(EAS 4d) of the biodegradation experiment. Samples are clustered in a single group based on the 
DNA sequences. Results of the cluster analysis are based at the Bray-Curtis distance (70%; 80%) 
and superimposed on the MDS ordination. 
EAS 0d = enriched activated sludge culture sampled at Day 0 
EAS 4d (w glu) = enriched activated sludge culture growing with glucose; sampled at Day 4 








Fig. S13. Differences in the microbial community composition between original activated sludge 
culture (OAS) collected at the WWTP (Zagreb) site enriched activated sludge culture during 
TRAM biodegradation experiment, represented on the level of different bacterial genera, 
determined based on sequencing of the V4 variable region of the 16S rRNA gene marker. 
EAS 0. day = enriched activated sludge culture sampled at Day 0 
EAS 4d (w glu) = enriched activated sludge culture growing with glucose; sampled at Day 4 







Table S4. Number of the observed species (OTUs, 97% cutoff value) within original activated 
sludge culture and enriched activated sludge culture collected and analyzed during TRAM 




Chao Shannon Simpson 
Original Sludge culture 1526 2937 7.7 0.98 
Enriched activated sludge culture 
0. day 
494 924 4.1 0.78 
Enriched activated sludge culture (w glu) 
4th day  
469 815 4.0 0.79 
Enriched activated sludge culture (w/o glu) 
4th day  
512 887 4.8 0.90 
 
 
